methyl 4-(3-cyclohexen-1-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate

methyl 4-(3-cyclohexen-1-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate Struktur
433257-61-5
CAS-Nr.
433257-61-5
Englisch Name:
methyl 4-(3-cyclohexen-1-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate
Synonyma:
methyl 6-(cyclohex-3-en-1-yl)-2-hydroxy-4-methyl-1,6-dihydropyrimidine-5-carboxylate;methyl 4-(3-cyclohexen-1-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate;5-Pyrimidinecarboxylic acid, 4-(3-cyclohexen-1-yl)-1,2,3,4-tetrahydro-6-methyl-2-oxo-, methyl ester
CBNumber:
CB14015742
Summenformel:
C13H18N2O3
Molgewicht:
250.29
MOL-Datei:
433257-61-5.mol

methyl 4-(3-cyclohexen-1-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate Eigenschaften

Siedepunkt:
359.0±42.0 °C(Predicted)
Dichte
1.162±0.06 g/cm3(Predicted)
pka
12.00±0.70(Predicted)

Sicherheit

methyl 4-(3-cyclohexen-1-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate Chemische Eigenschaften,Einsatz,Produktion Methoden

methyl 4-(3-cyclohexen-1-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


methyl 4-(3-cyclohexen-1-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
OTAVA chemicals --
north.america@otavachemicals.com Ukraine 6495 72
VITAS-M LABORATORY, LTD. --
Russia 6754 64
Interbioscreen Ltd. --
screen@ibscreen.chg.ru Finland 6178 60
Specs --
info@specs.net The Netherlands 6835 70
PHARMEKS Ltd. --
sales@pharmeks.com Finland 6350 50

  • 5-Pyrimidinecarboxylic acid, 4-(3-cyclohexen-1-yl)-1,2,3,4-tetrahydro-6-methyl-2-oxo-, methyl ester
  • methyl 6-(cyclohex-3-en-1-yl)-2-hydroxy-4-methyl-1,6-dihydropyrimidine-5-carboxylate
  • methyl 4-(3-cyclohexen-1-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate
  • 433257-61-5
Copyright 2019 © ChemicalBook. All rights reserved